Order Article Reprints

Castaldelli-Maia JM, Malbergier A, de Oliveira ABP, Amaral RA, Negrão AB, Gonçalves PD, Ventriglio A, de Berardis D, de Antonio J, Firigato I, et al. Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder. Biomolecules. 2021; 11(10):1495. https://doi.org/10.3390/biom11101495

Castaldelli-Maia, João M., André Malbergier, Adriana B. P. de Oliveira, Ricardo A. Amaral, André B. Negrão, Priscila D. Gonçalves, Antonio Ventriglio, Domenico de Berardis, Juliana de Antonio, Isabela Firigato, and et al. 2021. "Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder" Biomolecules 11, no. 10: 1495. https://doi.org/10.3390/biom11101495

Castaldelli-Maia, J. M., Malbergier, A., de Oliveira, A. B. P., Amaral, R. A., Negrão, A. B., Gonçalves, P. D., Ventriglio, A., de Berardis, D., de Antonio, J., Firigato, I., Gattás, G. J. F., & de Toledo Gonçalves, F. (2021). Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder. Biomolecules, 11(10), 1495. https://doi.org/10.3390/biom11101495